Earlier this year, the Supreme Court addressed the “on-sale” provision of the AIA, 35 U.S.C. Sec 102(a), in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc . In this case, the patent owner, Helsinn, entered into a license agreement and a supply and purchase ...